An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
Rivers, J K
An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses. [electronic resource] - Archives of dermatology Oct 1997 - 1239-42 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0003-987X
Administration, Cutaneous
Adult
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Dermatitis, Irritant--etiology
Dermatologic Agents--administration & dosage
Diclofenac--administration & dosage
Erythema--chemically induced
Follow-Up Studies
Gels
Humans
Hyaluronic Acid--administration & dosage
Keratosis--drug therapy
Patient Compliance
Patient Satisfaction
Precancerous Conditions--drug therapy
Remission Induction
Safety
Skin Neoplasms--drug therapy
Skin Tests
Time Factors
An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses. [electronic resource] - Archives of dermatology Oct 1997 - 1239-42 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0003-987X
Administration, Cutaneous
Adult
Anti-Inflammatory Agents, Non-Steroidal--administration & dosage
Dermatitis, Irritant--etiology
Dermatologic Agents--administration & dosage
Diclofenac--administration & dosage
Erythema--chemically induced
Follow-Up Studies
Gels
Humans
Hyaluronic Acid--administration & dosage
Keratosis--drug therapy
Patient Compliance
Patient Satisfaction
Precancerous Conditions--drug therapy
Remission Induction
Safety
Skin Neoplasms--drug therapy
Skin Tests
Time Factors